TickerFacts.

Iqvia Holdings Inc. (IQV): Cash & Equivalents

Annual figures by period end, from SEC filings.

$1.98B
As of 2025-12-31
$1.95B
As of 2026-03-31
+17.6%
3-year compound annual growth
+1.8%
5-year compound annual growth
+7.3%
10-year compound annual growth
2011-12-31: $516.30M2012-12-31: $567.73M2013-12-31: $778.14M2014-12-31: $867.00M2015-12-31: $977.00M2016-12-31: $1.20B2017-12-31: $959.00M2018-12-31: $891.00M2019-12-31: $837.00M2020-12-31: $1.81B2021-12-31: $1.37B2022-12-31: $1.22B2023-12-31: $1.38B2024-12-31: $1.70B2025-12-31: $1.98B$1.98B
2011-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$1.98B+16.3%2026-02-17, Balance as of period end
2024-12-31$1.70B+23.7%2026-02-17, Balance as of period end
2023-12-31$1.38B+13.2%2025-02-13, Balance as of period end
2022-12-31$1.22B-11.0%2024-02-15, Balance as of period end
2021-12-31$1.37B-24.7%2023-02-15, Balance as of period end
2020-12-31$1.81B+116.7%2022-02-16, Balance as of period end
2019-12-31$837.00M-6.1%2021-02-12, Balance as of period end
2018-12-31$891.00M-7.1%2020-02-18, Balance as of period end
2017-12-31$959.00M-19.9%2019-02-19, Balance as of period end
2016-12-31$1.20B+22.6%2019-02-19, Balance as of period end
2015-12-31$977.00M+12.7%2018-02-16, Balance as of period end
2014-12-31$867.00M+11.4%2017-02-16, Balance as of period end
2013-12-31$778.14M+37.1%2016-02-11, Balance as of period end
2012-12-31$567.73M+10.0%2015-02-12, Balance as of period end
2011-12-31$516.30Mn/a2014-02-13, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Iqvia Holdings Inc. (IQV)2025-12-31$1.98B+16.3%
Icon PLC (ICLR)2025-12-31$647.29M+20.1%
Incyte Corp (INCY)2025-12-31$3.10B+83.5%
Charles River Laboratories International, Inc. (CRL)2025-12-27$213.77M+9.8%
Medpace Holdings, Inc. (MEDP)2025-12-31$497.05M-25.8%
NRC Health (NRC)2025-12-31$4.14M-2.2%
MaxCyte, Inc. (MXCT)2025-12-31$20.07M-28.0%
OmniAb, Inc. (OABI)2025-12-31$25.52M-7.5%
Foxo Technologies Inc. (FOXO)2025-12-31$207.5K+203.9%

Compare IQV, ICLR, INCY, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗